MDNews - Lower Hudson/Bronx

November 2018

Issue link: https://viewer.e-digitaledition.com/i/1049957

Contents of this Issue

Navigation

Page 5 of 23

B Y I N C O R P O R AT I N G T H E rapid ly evolving benefits of precision medicine, NewYork-Presbyterian Lawrence builds on its longsta nding com m itment to delivering high-level care in the region. DEFINING PRECISION MEDICINE The Precision Medicine Initiative (PMI), launched in 2016, def ines precision medicine as an approach to preventing a nd treating disease "that ta kes into account individual variability in genes, env i ron ment a nd l i fest yle for ea ch person." This fosters greater accuracy in customizing prevention and treatment strategies that work best in particular patient groups, rather than focusing on the average patient with little regard to variation among individuals. Some aspects of precision medicine, such as matching donor and recipient blood types for transfusions, were in practice long before the term came into w idespread use, notes t he Nationa l Institutes of Hea lth, which is part of the PMI. However, clinical research has moved the field forward to an astonishing degree, notably in oncology. NYP Lawrence and a dedicated team of Columbia University Medical Center (C U MC ) s p e c i a l i s t s e m b r a c e t h e potentia l of precision medicine with a n approach comprising ever y t hing f r o m e x a m i n i n g c a n c e r p a t i e n t s ' family histories and analyzing patients' here d it a r y pre d i sposit ion s t ow a rd ca ncer to determining a nd apply ing the most effective courses of treatment based on eva luations of tumor genetics. " E ver y pa t ient c a n b enef it f r om preci sion med ici ne," say s Hen r y J. Lee, MD, PhD, Director of R adiation O n c o l o g y a t N Y P L a w r e n c e a n d A s s i s t a n t P r o f e s s o r o f R a d i a t i o n Oncolog y at CUMC. THE NE W YORK-PRESBY TERIAN L AWRENCE HOSPITAL CANCER CENTER LE VER AGES THE ACADEMIC AND CLINICAL PROWESS OF COLuMBIA uNIVERSIT Y IRVING MEDICAL CENTER SPECIALISTS TO PROVIDE PATIENTS IN THE BRONx AND WESTCHESTER ARE A S WITH ACCuR ATE, COMPREHENSIVE DIAGNOSES AND LE ADING-EDGE THER APIES MADE POSSIBLE BY ADVANCES IN PRECISION MEDICINE. NewYork-Presbyterian Lawrence Hospital: Personalizing Cancer Care with Cutting-Edge Precision Medicine BY SHERI LEVISAY Henry Lee, MD, PhD, is Director of Radiation Oncology at NewYork-Presbyterian Lawrence Hospital and an active member of Columbia University's Herbert Irving Comprehensive Cancer Center. As a leader in the field, Dr. Lee utilizes the latest technologies to treat patients with precision medicine tools that zero in on tumors and spare healthy tissues. Photos © Paul Moore, Paul Moore Studio 0 6❱❱❱❱❱ C O V E R F E A T u R E

Articles in this issue

Archives of this issue

view archives of MDNews - Lower Hudson/Bronx - November 2018